Recently, President of Medtronic's Gastrointestinal Business Gio Di Napoli
, announcing that he will resign from his position at this medical technology giant.

Three Department Presidents Resign in Two Months

His departure marks the second business unit president to leave Medtronic this month.Three Business Unit Presidents Leave in Two Months.On March 17, the companyPresident of the Respiratory Interventions Division, Ariel MactavishAlso announced that she will leave the company. Previously, Medtronic announced its exit from the ventilator market in February, at the same time, MedtronicExecutive Vice President and President of the Medical Surgical Portfolio, Bob WhiteWill also leave the company at the same time.

Gio Di Napoli, the outgoing chairman of the GI department

Di Napoli announced on LinkedIn that his 16-year tenure at Medtronic has come to an end. He stated that putting "his family's future first" was the reason behind his decision.

He referred to Medtronic as “more than just a workplace,” expressing gratitude for the support and guidance of Jeff Martha, Mike Marinello, and Jennifer Stone. He also mentioned his pride in the endoscopy division and described his experience serving Medtronic customers as both a “privilege and an education.”

"Our time in the United States was incredible, but our hearts remained in Europe, where our family is," said Dinapoli.Wrote"At this critical moment in our daughters' lives, we long to be closer to them, which is why we moved back."

New President of the Endoscopy Division, former employee of Boston Scientific

Dinapoli also revealed,Raj Thomas to Serve as New President of Medtronic's Endoscopy DivisionAccording to Thomas's LinkedIn page, he actually started this position in February.

Thomas joined Medtronic in 2014 as the Program Director for Neuro modulation, Gastrointestinal and Urology. Over the past nine years, he has held multiple positions, with the most recent being Vice President and General Manager of Mechanical Circulatory Support.

Before joining Medtronic,Thomas has worked at Boston Scientific for over 14 years.Di Napoli said that Thomas brought "a wealth of knowledge, a visionary mindset, and a sincere commitment to excellence."

Dinapoli wrote: "He is known for putting patients first and fostering successful collaboration." "I believe that under his guidance, the endoscopy team will not only continue to thrive but also reach new heights in advancing healthcare and endoscopic care. I am excited to see the impact he will make."

He wrote: "While I am sad to be leaving, I am also excited because everything I've learned during this time will help shape the next step in my career, and I will share more details soon."

Partnering with NVIDIA to Expand AI + Endoscopy Business

In 2023,Medtronic has made significant progress in the endoscopic GI business, particularly in its collaboration with NVIDIA., jointly createdMedical Device AI Platform, this move marks an important step forward for the company in medical technology innovation. By integrating NVIDIA's healthcare and edge AI technologies, Medtronic's GI Genius™ intelligent endoscopy module has been significantly enhanced. Developed and manufactured by Cosmo Pharmaceuticals, this module is the first FDA-approved AI-assisted colonoscopy tool that helps physicians more effectively detect polyps that could develop into colorectal cancer. This integration embeds a set of AI algorithms within the GI Genius and combines it with NVIDIA’s Clara healthcare platform, accelerating the development of real-time medical procedure algorithms, thereby driving AI innovation and improving patient care.

With the addition of NVIDIA technology,Medtronic and Cosmo Pharmaceuticals Launch Innovative Center Website, allowing third-party developers to effectively train and validate their own AI models using a cloud-based platform. These AI-powered applications can then be hosted on Medtronic's Software as a Medical Device (SaMD) app marketplace — the GI Genius AI Access™ platform, realizing the potential of software-defined medical devices.

Medtronic and NVIDIA's Collaboration Drives Innovation in the Medical Device Industry

A Series of Personnel Changes Reflect a New Industrial Layout

In addition to the departure of the presidents of three departments, Medtronic's frequent personnel changes in recent times also indirectly reflect the direction of Medtronic's industrial layout.

Among them, Que Dallara serves as the President of the Diabetes Business:On March 17, Medtronic announced that Que Dallara would join the company as President of the Diabetes Business and Executive Vice President of Medtronic. Dallara previously served as President and CEO of Honeywell's Industrial Software Business, bringing extensive management experience.

Mike Marinaro serves as the President of the Surgical Robotics Business Unit:Also in March, Mike Marinaro was appointed President of the Surgical Robotics Business Unit, having previously served as President of the Cardiac Rhythm Management Business Unit.

Kweli Thompson Appointed President of Heart Rhythm Management Business:Dr. Kweli Thompson Appointed President of Heart Rhythm Management Business Unit; Previously Served as Vice President and General Manager of Medtronic's Cardiac Resynchronization and Defibrillation Solutions Business

Change in China's R&D Vice President:Medtronic announced that Dr. Wang Xi will join the company on May 2nd as the Vice President of R&D in China, and will also become a member of the Greater China Executive Committee (GCEC) and Medtronic's Global R&D Committee.